1. Home
  2. PRLB vs STOK Comparison

PRLB vs STOK Comparison

Compare PRLB & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Proto Labs Inc.

PRLB

Proto Labs Inc.

HOLD

Current Price

$79.64

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$31.42

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRLB
STOK
Founded
1999
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
PRLB
STOK
Price
$79.64
$31.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
10
Target Price
$53.00
$39.20
AVG Volume (30 Days)
205.6K
609.8K
Earning Date
05-01-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
92.73
EPS
0.33
N/A
Revenue
N/A
$184,420,000.00
Revenue This Year
$8.56
N/A
Revenue Next Year
$6.89
$77.49
P/E Ratio
$246.12
N/A
Revenue Growth
N/A
404.50
52 Week Low
$38.48
$11.19
52 Week High
$83.15
$40.22

Technical Indicators

Market Signals
Indicator
PRLB
STOK
Relative Strength Index (RSI) 59.54 55.20
Support Level $52.62 $30.34
Resistance Level $83.15 $35.11
Average True Range (ATR) 2.98 1.54
MACD -0.09 0.28
Stochastic Oscillator 65.02 73.88

Price Performance

Historical Comparison
PRLB
STOK

About PRLB Proto Labs Inc.

Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. The Lab uses injection molding, computer numerical control machining, and 3-D printing, and sheet metal to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: